The Use of tDCS in the Orofacial Pain

Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Oct 14, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called transcranial direct current stimulation (tDCS) for people suffering from orofacial pain, which is pain in the jaw, mouth, or face. The goal is to find out how effective this treatment is and how long its effects last, especially for those who haven’t found relief with traditional pain medications. Participants in the trial will receive either the actual tDCS treatment or a placebo (a treatment that looks the same but doesn’t have any active ingredients) during six sessions over two weeks. Researchers will measure not only the pain relief but also any changes in mood, anxiety, and overall quality of life.

To be eligible, participants need to have a diagnosis of orofacial pain confirmed by a specialist and must be on a stable pain management plan for at least a month prior to starting the study. Those who are pregnant, have certain health conditions like epilepsy or heart problems, or have recently changed their pain medication are not able to participate. Throughout the 26 weeks of the study, participants will keep track of their pain levels using a simple daily rating scale. By participating, individuals may receive valuable treatment for their pain and contribute to important research that could help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of Orofacial Pain by a pain medicine specialist according to ICOP (International classification of orofacial pain) and ICHD3 (International classification of headache disorder)
• • Stable analgesic therapy one month before the stimulation series
• Exclusion Criteria:
• • Changes to the analgesic therapy in 6 months following the stimulation series
• • Non-compliance with the follow-ups
• • General contraindications to tDCS - pregnancy, unstable cardiovascular disorders, epilepsy and intracranial masses